None
Quote | Charles River Laboratories International Inc. (NYSE:CRL)
Last: | $199.66 |
---|---|
Change Percent: | 0.0% |
Open: | $201.42 |
Close: | $199.66 |
High: | $201.92 |
Low: | $197.5 |
Volume: | 515,372 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Charles River Laboratories International Inc. (NYSE:CRL)
2024-07-06 07:45:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. During the quarter, a ...
2024-06-28 13:20:06 ET More on Charles River Laboratories Charles River Laboratories: Fair Valuation Against Fundamentals Charles River Laboratories International, Inc. (CRL) Q1 2024 Earnings Call Transcript Mizuho starts Charles River Labs at neutral, cites near-ter...
Message Board Posts | Charles River Laboratories International Inc. (NYSE:CRL)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CRL News Article - Trading Charles River $CRL With Integrated Risk Controls | whytestocks | investorshangout | 04/24/2023 7:40:49 PM |
whytestocks: $CRL News Article - INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investi | whytestocks | investorshangout | 02/23/2023 8:25:48 PM |
whytestocks: $CRL News Article - Why Charles River Laboratories Stock Is Jumping Today | whytestocks | investorshangout | 11/02/2022 4:30:52 PM |
whytestocks: $CRL News Article - Charles River Laboratories Announces Third-Quarter 2022 Results | whytestocks | investorshangout | 11/02/2022 3:25:50 PM |
whytestocks: $CRL News Article - Charles River Laboratories Publishes 2021 Corporate Citizenship Rep | whytestocks | investorshangout | 04/07/2022 4:30:49 PM |
News, Short Squeeze, Breakout and More Instantly...
Charles River Laboratories International Inc. Company Name:
CRL Stock Symbol:
NYSE Market:
Charles River Laboratories International Inc. Website:
Lentiviral vector CDMO collaboration to support advanced cell therapies for hematological cancers Charles River Laboratories International, Inc. (NYSE: CRL) and the Gates Institute at the University of Colorado Anschutz Medical Campus today announced a lentiviral vector contract...
2024-06-18 18:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Leveraging CGT CDMO expertise to support T-cell immunotherapy clinical trial Charles River Laboratories International, Inc. (NYSE: CRL) and Captain T Cell, a spinoff from the renowned Max Delbrück Center Berlin, Germany, today announced a plasmid DNA and retrovirus vector productio...